Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

ClinicalTrials.gov ID: NCT00761462

Public ClinicalTrials.gov record NCT00761462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-label, Non-randomized, Naturalistic, Long-term Safety Surveillance, Observational Study of Either Ciprofloxacin (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) or a Non-quinolone Antibiotic (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) in the Treatment of Pediatric Patients With Infectious Diagnoses

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Objective and subjective musculoskeletal evaluations will be performed to determine differences in the ciprofloxacin versus non-quinolone treated pediatric patients so that we can tell what the natural occurrence of such musculoskeletal conditions is in the general pediatric population.

Study identification

NCT ID
NCT00761462
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
1,029 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Months to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1999 (Type not available)
Primary completion
Jan 2008 (Actual)
Completion
Jan 2008 (Actual)
Last update posted
Jul 31, 2015

1999 – 2008

United States locations

U.S. sites
66
U.S. states
29
U.S. cities
61
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Fort Smith Arkansas 72903 —
Not listed Corona California 92879 —
Not listed Fountain Valley California 92708 —
Not listed Long Beach California 90806 —
Not listed Orange California 92868-3974 —
Not listed Pico Rivera California 90660 —
Not listed San Bernardino California 92411 —
Not listed San Luis Obispo California 93405 —
Not listed Centennial Colorado 80112 —
Not listed Denver Colorado 80218 —
Not listed Fort Walton Beach Florida 32548 —
Not listed Gainesville Florida 32610-0254 —
Not listed Hialeah Florida 33013 —
Not listed Jacksonville Florida 32209 —
Not listed Jupiter Florida 33458 —
Not listed Miami Florida 33155 —
Not listed Pensacola Florida 32504 —
Not listed Tampa Florida 33606 —
Not listed Tampa Florida 33607 —
Not listed Snellville Georgia 30078 —
Not listed Honolulu Hawaii 96813 —
Not listed Idaho Falls Idaho 83404 —
Not listed Park Ridge Illinois 60068-1174 —
Not listed Springfield Illinois 62701 —
Not listed Indianapolis Indiana 46202 —
Not listed Overland Park Kansas 66215 —
Not listed Bardstown Kentucky 40004 —
Not listed New Orleans Louisiana 70118-5799 —
Not listed Boston Massachusetts 02115 —
Not listed Red Wing Minnesota 55066-0095 —
Not listed Omaha Nebraska 68114 —
Not listed Omaha Nebraska 68131 —
Not listed Las Vegas Nevada 89109 —
Not listed Hackensack New Jersey 07601-1991 —
Not listed Voorhees Township New Jersey 08043 —
Not listed New Hyde Park New York 11040 —
Not listed New York New York 10021-4885 —
Not listed New York New York 10032 —
Not listed Stony Brook New York 11794-8111 —
Not listed The Bronx New York 10461 —
Not listed Durham North Carolina 27710 —
Not listed Wilmington North Carolina 28401 —
Not listed Akron Ohio 44308-1062 —
Not listed Cleveland Ohio 44109-1998 —
Not listed Dayton Ohio 45404-1815 —
Not listed Youngstown Ohio 44501-0240 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Oklahoma City Oklahoma 73120 —
Not listed Tulsa Oklahoma 74135 —
Not listed Elverson Pennsylvania 19520 —
Not listed Havertown Pennsylvania 19083 —
Not listed Charleston South Carolina 29425 —
Not listed Memphis Tennessee 38105-2729 —
Not listed Austin Texas 78756 —
Not listed Benbrook Texas 76126 —
Not listed El Paso Texas 79925 —
Not listed Fort Worth Texas 76104 —
Not listed Galveston Texas 77555-0371 —
Not listed Houston Texas 77024 —
Not listed Houston Texas 77030 —
Not listed Temple Texas 76508 —
Not listed Layton Utah 84041 —
Not listed Norfolk Virginia 23510 —
Not listed Richmond Virginia 23298 —
Not listed Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00761462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2015 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00761462 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →